Notes to Condensed Consolidated Financial
Statements
(Unaudited)
1.
|
SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES
|
The following accounting principles and practices
are set forth to facilitate the understanding of data presented in the condensed consolidated financial statements:
Nature of operations and principles of consolidation
Workhorse Group Inc. and its predecessor companies
(“Workhorse”, the “Company”, “we”, “us” or “our”) is a technology company
focused on providing sustainable and cost-effective solutions to the commercial transportation sector. As an American manufacturer,
we design and build high performance battery-electric vehicles and aircraft that make movement of people and goods more efficient
and less harmful to the environment. As part of our solution, we also develop cloud-based, real-time telematics performance monitoring
systems that enable fleet operators to optimize energy and route efficiency. Although we operate as a single unit through our subsidiaries,
we approach our development through two divisions, Automotive and Aviation. We are currently focused on our core competency of
bringing the N-GEN electric cargo van to market and fulfilling our existing backlog of orders. We are also exploring other opportunities
in monetizing our intellectual property which could include a sale, license or other arrangement of assets that are outside of
our core focus.
The Company’s wholly owned subsidiaries include
Workhorse Technologies Inc., Workhorse Motor Works Inc. and Workhorse Properties Inc.
Basis of presentation
The financial statements have been prepared on a going
concern basis, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However,
the Company has limited revenues and a history of negative working capital and stockholders’ deficits. Our existing capital
resources will be insufficient to fund our operations through the first half of 2019. Unless and until we are able to generate
a sufficient amount of revenue, reduce our costs and/or enter a strategic relationship, we expect to finance future cash needs
through public and/or private offerings of equity securities and /or debt financings. If we are not able to obtain additional financing
and/or substantially increase revenue from sales, we will be unable to continue as a going concern. These conditions raise substantial
doubt about the ability of the Company to continue as a going concern.
In view of these matters, continuation as a going
concern is dependent upon the continued operations of the Company, which, in turn, is dependent upon the Company’s ability
to meet its financial requirements, raise additional capital, and successfully carry out its future operations. The financial statements
do not include any adjustments to the amount and classification of assets and liabilities that may be necessary, should the Company
not continue as a going concern.
The Company has continued to
raise capital. Management believes the proceeds from these offerings, future offerings, and the Company’s anticipated
revenue, provides an opportunity to continue as a going concern. If additional funding is required, the Company plans
to obtain working capital from either debt or equity financing from the sale of common stock, preferred stock, and/or convertible
debentures. Obtaining such working capital is not assured. The Company is currently in a production ramp up mode and placing greater
emphasis on manufacturing capability.
In
the opinion of Management, the Unaudited Condensed Consolidated Financial Statements include all adjustments that are necessary
for the fair presentation of Workhorse’s respective financial conditions, results of operations and cash flows for the interim
periods presented. Such adjustments are of a normal, recurring nature. Intercompany balances and transactions are eliminated
in consolidation. The results of operations and cash flows for the interim periods presented may not necessarily be indicative
of full-year results. It is suggested that these financial statements be read in conjunction with the audited consolidated
financial statements and notes thereto of Workhorse contained in its Annual Report on Form 10-K for the year ended December 31,
2018
.
The preparation of financial statements in conformity
with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported
in the financial statements and accompanying notes. Actual results could differ from these estimates.
Certain reclassifications were
made to the prior year financial statements to conform to the current year presentation. These reclassifications had no effect
on previously reported results of operation or stockholders’ equity.
As of March 31, 2019, and December
31, 2018, our inventory consisted of the following:
|
|
2019
|
|
|
2018
|
|
Raw materials
|
|
$
|
4,276,819
|
|
|
$
|
4,319,637
|
|
Work in process
|
|
|
702,079
|
|
|
|
702,079
|
|
Finished goods
|
|
|
-
|
|
|
|
-
|
|
|
|
|
4,978,898
|
|
|
|
5,021,716
|
|
Less: Inventory reserve
|
|
|
2,488,100
|
|
|
|
2,488,100
|
|
|
|
$
|
2,490,798
|
|
|
$
|
2,533,616
|
|
Revenue Recognition
Net sales include products and
shipping and handling charges, net of estimates for customer allowances. Revenue is measured as the amount of consideration we
expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations
under the contract. We recognize revenue by transferring the promised products to the customer, with the majority of revenue recognized
at the point in time the customer obtains control of the products. We recognize revenue for shipping and handling charges at the
time the products are delivered to or picked up by the customer. The majority of our contracts have a single performance obligation
and are short term in nature.
Accounts Receivable
Credit is extended based upon
an evaluation of the customer’s financial condition. Accounts receivable are stated at their estimated net realizable value. The
allowance for doubtful accounts is based on an analysis of customer accounts and our historical experience with accounts receivable
write-offs.
The Company has elected the following practical
expedients allowed under ASU 2014-09:
|
·
|
Performance
obligations are satisfied within one year from a given reporting date, consequently we omit disclosure of the transaction price
apportioned to remaining performance obligations on open orders
|
Disaggregation of Revenue
Our revenues related to the following types of business
were as follows for the periods ended March 31:
|
|
Three Months Ended
|
|
|
|
2019
|
|
|
2018
|
|
Automotive
|
|
$
|
240,000
|
|
|
$
|
404,854
|
|
Aviation
|
|
|
-
|
|
|
|
-
|
|
Other
|
|
|
124,182
|
|
|
|
155,375
|
|
Total revenues
|
|
$
|
364,182
|
|
|
$
|
560,229
|
|
Debt consists of the
following:
|
|
March 31,
2019
|
|
|
December 31,
2018
|
|
Marathon Tranche One Loan, due December 31, 2021, interest only quarterly payments, variable interest
rate of 10.4% as of March 31, 2019 (discount is based on warrant valuation of approximately 9.7%)
|
|
$
|
10,000,000
|
|
|
$
|
10,000,000
|
|
Marathon Tranche Two Loan, due December 31, 2021, interest only quarterly payments, variable interest
rate of 10.4% as of March 31, 2019 (discount is based on warrant valuation of approximately 9.7%)
|
|
|
4,104,140
|
|
|
|
-
|
|
Marathon Credit Agreement unamortized discount and issuance costs
|
|
|
(1,558,871
|
)
|
|
|
(1,687,921
|
)
|
Net Marathon Credit Agreement
|
|
|
12,545,269
|
|
|
|
8,312,079
|
|
Less current portion
|
|
|
4,104,140
|
|
|
|
-
|
|
Long-term debt
|
|
$
|
8,441,129
|
|
|
$
|
8,312,079
|
|
On December 31, 2018, the
Company entered into a Credit Agreement (the “Credit Agreement”), among the Company, as borrower, Marathon Asset
Management, LP, on behalf of certain entities it manages, as lenders (collectively, with their permitted successors and
assignees, the “Lenders”), and Wilmington Trust, National Association, as the agent (“Wilmington”).
The Credit Agreement provided the Company with a $10 million tranche of term loans (the “Tranche One
Loans”) which may not be re-borrowed following repayment and (ii) a $25 million tranche of revolving loans which may be
re-borrowed following repayment (the “Tranche Two Loans” together with the Tranche One Loans, the
“Loans”).
In accordance with the
Credit Agreement, the Company issued each Lender a Common Stock Purchase Warrant to purchase, in the aggregate, 8,053,390
shares of common stock of the Company at an exercise price of $1.25 per share exercisable in cash only for a period of three
years and then for cash or cashless thereafter (collectively, the “Initial Warrants”). Until the later of the
repayment of all obligations owed to the Lenders or two years from the closing date, the Company will be required to issue
additional Common Stock Purchase Warrants (the “Additional Warrants”) to the Lenders equal to 10%, in the
aggregate, of any additional equity issuances, subject to certain exceptions, on substantially the same terms and conditions
of the Initial Warrants, except that (i) the applicable expiration date thereof shall be five years from the issuance date of
the applicable warrant, (ii) the initial exercise price shall be a price equal to the price per share of common stock used in
the relevant issuance multiplied by 110% and (iii) the holder shall be entitled to exercise the warrant on a cashless
exercise at any time the warrant is exercisable.
Principal amounts:
|
|
At
March 31,
2019
|
|
Tranche One - Principal
|
|
$
|
10,000,000
|
|
Tranche Two – Current amount drawn
|
|
|
4,104,140
|
|
Unamortized debt discount and issuance costs (1)
|
|
|
(1,558,871
|
)
|
Net debt carrying amount
|
|
$
|
12,545,269
|
|
Carrying amount of warrant the liability component (2)
|
|
$
|
1,295,637
|
|
|
(1)
|
Includes
the unamortized portion of the initial warrant liability of $965,747 and issuance costs of $722,174.
|
|
(2)
|
Includes
marked to market liability of initial Marathon warrant liability and subsequent warrant issuances.
|
|
5.
|
DUKE
FINANCING OBLIGATION
|
On November 28, 2018, the Company entered into a Sales
Agreement with Duke Energy One, Inc., a wholly-owned subsidiary of Duke Energy Corporation (NYSE: DUK) (“Duke”), pursuant
to which the Company sold Duke 615,000 battery cells (the “615,000 Cells”) in consideration of $1,340,700. Workhorse
will continue to use the cells in the near term for the delivery of trucks to UPS and DHL. Until May 1, 2019, the Company
has the right and option to require Duke to sell the 615,000 Cells back to the Company and Duke has the right and option to require
the Company to purchase the 615,000 Cells at price equal to the price the 615,000 Cells were sold.
On November 28, 2018, in consideration
for consenting to the Company selling the 615,00 Cells to Duke, which served as collateral for Arosa the Loan Agreement, the Company
entered into a Limited Consent, Waiver and Release with Arosa pursuant to which the Company issued Arosa 2,000,000 shares of common
stock and restruck the exercise price of warrants previously issued to Arosa to $1.25 per share. In addition, while the Arosa
Loan remained outstanding, the exercise price of the Arosa Warrants will be restruck to equal the price of any equity issued by
the Company, including the issuance of any common stock purchase warrants or other derivative convertible securities, if the issuing
price of such securities is less than $1.25.
On April 30, 2019, Duke and the
Company entered into an agreement to amend the initial Sales Agreement to extend the expiration date from May 1, 2019 to October
15, 2019.
The Duke transactions was accounted
for as a financing obligation and as such, the Company has recorded a $1,340,700 liability related to the transaction.
6.
|
STOCK BASED COMPENSATION
|
Options to directors, officers, consultants
and employees
The Company maintains, as adopted by the board of
directors, the 2017 Stock Incentive Plan, the 2016 Stock Incentive Plan, the 2014 Stock Incentive Plan, the 2014 Stock Compensation
Plan, 2013 Incentive Stock Plan, the 2012 Incentive Stock Plan, the 2011 Incentive Stock Plan and the 2010 Stock Incentive Plan
(the “Plans”) providing for the issuance of options to employees, officers, directors or consultants of the Company.
Non-qualified stock options granted under the plans may only be granted with an exercise price equal to the fair market value of
the Company’s common stock on the date of grant. Awards under the plans may be either vested or unvested options.
The 2017 Stock Incentive Plan authorized 5,000,000 shares with vesting in sixteen equal quarterly tranches.
In addition to the Plans, the Company has granted,
on various dates, stock options to directors, officers, consultants and employees to purchase common stock of the Company. The
terms, exercise prices and vesting of these awards vary.
The following table summarizes option activity
for directors, officers, consultants and employees:
|
|
|
|
|
|
|
Outstanding Stock Options
|
|
|
|
|
Options Available for Grant
|
|
|
|
Number of Options
|
|
|
|
Weighted
Average
Exercise Price
per Option
|
|
|
|
Weighted
Average Grant
Date Fair Value
per Option
|
|
|
|
Weighted
Average
Remaining
Exercise Term
in Months
|
|
Balance December 31, 2017
|
|
|
4,145,774
|
|
|
|
3,851,371
|
|
|
|
3.11
|
|
|
|
1.84
|
|
|
|
43
|
|
Additional stock reserved
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Granted
|
|
|
(340,000
|
)
|
|
|
340,000
|
|
|
|
1.18
|
|
|
|
0.54
|
|
|
|
56
|
|
Exercised
|
|
|
-
|
|
|
|
(52,500
|
)
|
|
|
1.24
|
|
|
|
0.68
|
|
|
|
-
|
|
Forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Expired
|
|
|
-
|
|
|
|
(271,250
|
)
|
|
|
3.22
|
|
|
|
1.58
|
|
|
|
-
|
|
Balance December 31, 2018
|
|
|
3,805,774
|
|
|
|
3,867,621
|
|
|
$
|
4.05
|
|
|
$
|
1.84
|
|
|
|
64
|
|
Additional stock reserved
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
(2,000,000
|
)
|
|
|
2,000,000
|
|
|
|
0.97
|
|
|
|
0.55
|
|
|
|
88
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
1,359,069
|
|
|
|
(1,359,069
|
)
|
|
|
4.73
|
|
|
|
1.94
|
|
|
|
31
|
|
Expired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance March 31, 2019
|
|
|
3,164,843
|
|
|
|
4,508,552
|
|
|
$
|
2.48
|
|
|
$
|
1.24
|
|
|
|
65
|
|
As the Company has not generated
taxable income since inception, the cumulative deferred tax assets remain fully reserved, and no provision or liability for federal
or state income taxes has been included in the financial statements.
Basic loss per share is computed
by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator)
during the period. For all periods presented, all of the Company’s common stock equivalents were excluded from the calculation
of diluted loss per common share because they were anti-dilutive, due to the Company’s net losses.
|
9.
|
RECENT
ACCOUNTING DEVELOPMENTS
|
Accounting Guidance Adopted
in 2018
Effective January 1, 2018, we
adopted Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) No. 2016-10, Revenue from Contracts with
Customers (Topic 606): Identifying Performance Obligations and Licensing, and affects the guidance in ASU No. 2014-09, Revenue
from Contracts with Customers (Topic 606). ASU No. 2016-10 clarifies the following two aspects of Topic 606: evaluating whether
promised goods and services are separately identifiable and determining whether an entity’s promise to grant a license provides
a customer with either a right to use the entity’s intellectual property, which is satisfied at a point in time, or a right
to access the entity’s intellectual property, which is satisfied over time. The Company adopted ASU No. 2016-10, using the
modified retrospective approach, which did not have a material impact on the Company’s condensed consolidated financial statements.
Additional information is available in Note 4, “Revenue.”
Effective January 1, 2018, we
adopted FASB ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting
Revenue Gross versus Net), and affects the guidance in ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).”
. When another party is involved in providing goods or services to a customer, ASU No. 2014-09 requires an entity to determine
whether the nature of its promise is to provide the specified good or service itself (that is, the entity is a principal) or to
arrange for that good or service to be provided by the other party (that is, the entity is an agent). The amendments in ASU No.
2016-08 are intended to improve the operability and understandability of the implementation guidance in ASU No. 2014-09 on principal
versus agent considerations by offering additional guidance to be considered in making the determination. The Company adopted ASU
No. 2016-08, using the modified retrospective approach, which did not have a material impact on the Company’s condensed consolidated
financial statements. Additional information is available in Note 4, “
Revenue.
”
Accounting Guidance Adopted
in 2019
In February 2016, the FASB issued
ASU No. 2016-02, Leases (Topic 842), which requires a lessee to recognize in the statement of financial position a liability to
make lease payments (“the lease liability”) and a right-of-use asset representing its right to use the underlying
asset for the lease term, initially measured at the present value of the lease payments. When measuring assets and liabilities
arising from a lease, the lessee should include payments to be made in optional periods only if the lessee is reasonably certain,
as defined, to exercise an option to the lease or not to exercise an option to terminate the lease. Optional payments to purchase
the underlying asset should be included if the lessee is reasonably certain it will exercise the purchase option. Most variable
lease payments should be excluded except for those that depend on an index or a rate or are in substance fixed payments. A lessee
shall classify a lease as a finance lease if it meets any of five listed criteria: 1) The lease transfers ownership of the underlying
asset to the lessee by the end of the lease term. 2) The lease grants the lessee and option to purchase the underlying asset that
the lessee is reasonably certain to exercise. 3) The lease term is for the major part of the remaining economic life of the underlying
asset. 4) The present value of the sum of the lease payments and any residual value guaranteed by the lessee equals or exceeds
substantially all of the fair value of the underlying asset. 5) The underlying asset is of such a specialized nature that it is
expected to have no alternative use to the lessor at the end of the lease term. For finance leases, a lessee shall recognize in
the statement of comprehensive income interest on the lease liability separately from amortization of the right-of-use asset.
Amortization of the right-of-use asset shall be on a straight-line basis, unless another basis is more representative of the pattern
in which the lessee expects to consume the right-of-use asset’s future economic benefits. If the lease does not meet any
of the five criteria, the lessee shall classify it as an operating lease and shall recognize a single lease cost on a straight-line
basis over the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election
by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize
lease expense for such leases generally on a straight-line basis over the lease term. The amendments in this update were applied
using the current period adjustment method, as defined, and were effective on January 1, 2019. The adoption of this standard did
not have a material impact on the condensed consolidated financial statements.
On June 22, 2017, the Company
entered into an at the market issuance sales agreement (the “Cowen Agreement”) with Cowen and Company, LLC
(“Cowen”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its Common
Stock having an aggregate offering price of up to $25.0 million through Cowen as its sales agent. As of March 31, 2019, the Company
issued 4,464,777 shares from this facility for proceeds of approximately $8.7 million.
On September 14, 2017, the Company
entered into an underwriting agreement (the “Underwriting Agreement”) with Cowen relating to the public offering and
sale (the “Offering”) of 3,749,996 shares of the Company’s common stock, and five-year warrants (exercisable
beginning on the date of issuance) to purchase up to an aggregate of 2,812,497 shares of the Company’s common stock. Each
investor received a warrant to purchase 0.75 shares of the Company’s common stock at an exercise price of $3.80 per share,
for each share of common stock purchased.
Pursuant to the Underwriting
Agreement, Cowen purchased 3,749,996 shares of the Company’s common stock and accompanying warrants at a price per share
of $3.20. The net proceeds to the Company were approximately $10.9 million after deducting underwriting discounts and
commissions and offering expenses. The sale of such shares and accompanying warrants closed on September 18, 2017. The
warrants contain full ratchet anti-dilution protection upon the issuance of any common stock, securities convertible into common
stock or certain other issuances at a price below the then existing exercise price of the warrants, with certain exceptions.
On June 4, 2018, the Company
and holders of all outstanding Warrants to Purchase Common Stock of the Company issued September 18, 2017 (collectively, the “Warrants”)
entered into separate, privately-negotiated exchange agreements (the “Exchange Agreements”), pursuant to which the
Company issued to such holders an aggregate of 1,968,736 shares of the Company’s common stock in exchange for the Warrants.
The closing of the exchanges contemplated by the Exchange Agreements occurred on June 5, 2018. In addition, the “Down Round”
feature of the Warrants was triggered in the second quarter of 2018, causing the strike price to decrease from $3.80 per share
to $2.62 per share. As a result, the Company recorded approximately $765,179 as a deemed dividend which represents the value transferred
to the Warrant holders due to the Down Round being triggered. The deemed dividend was recorded as a reduction of Retained Earnings
and increase in Additional Paid-in-Capital and reduced net income available to common shareholders by the same amount.
On August 9, 2018, the Company
entered into an Underwriting Agreement (the “Underwriting Agreement”) with National Securities Corporation (the “Underwriter”),
relating to the public offering and sale (the “2018 Offering”) of 9,000,000 shares of our Common Stock at a price per
share of $1.15 for aggregate gross proceeds of $10.4 million. This offering closed on August 13, 2018. Pursuant to the
Underwriting Agreement, the Company granted the Underwriter a 45-day option to purchase from the Company up to an additional 1,350,000
shares of Common Stock at the offering price to cover over allotments, if any. On August 14, 2018, the Underwriter exercised its
over-allotment option and acquired an additional 1,288,800 shares of Common Stock at a price per share of $1.15 for aggregate gross
proceeds of $1.4 million. The over-allotment closing occurred on August 14, 2018. The Company used the net proceeds from this offering
for working capital, general corporate purposes and repayment of debt and other obligations.
Commencing February 11, 2019, the Company entered into and closed Subscription Agreements with accredited
investors (the “February 2019 Accredited Investors”) pursuant to which the February 2019 Accredited Investors purchased
1,499,684 shares of the Company’s common stock for a purchase price of $1,365,000. If, prior to the six month anniversary,
the Company issues shares of its common stock for a purchase price per share less than the purchase price paid by the February
2019 Accredited Investors subject to standard carve-outs (a “Down Round”), the Company will issue additional shares
of common stock (for no additional consideration) to the February 2019 Accredited Investors such that the effective purchase price
per share is equal to the purchase price per share paid in the Down Round. Benjamin Samuels and Gerald Budde, directors of the
Company, acquired 841,928 and 26,310 shares of common stock, respectively, as part of this offering, provided, however, their per
share purchase was $0.9501, which was above the closing price the date prior to close and they did not receive the Down Round protection.
The Company evaluates events
and transactions occurring subsequent to the date of the condensed consolidated financial statements for matters requiring recognition
or disclosure in the condensed consolidated financial statements. The accompanying condensed consolidated financial statements
consider events through the date on which the condensed consolidated financial statements were available to be issued.
Second
Amendment to Credit Agreement
On April 1, 2019, the Company
entered into the Second Amendment to Credit Agreement (the “Marathon Second Amendment”), among the Company, as borrower,
certain affiliates of Marathon Asset Management, LP, as lenders (collectively, with their permitted successors and assignees, the
“Lenders”), and Wilmington Trust, National Association, as the agent (“Wilmington”) amending certain terms
of the Credit Agreement, dated as of December 31, 2018 (as amended, restated, amended and restated or otherwise modified prior
to the date hereof), between the Company, the Lenders and Wilmington. The Marathon Second Amendment delayed the application of
certain financial covenants including:
|
(i)
|
the minimum liquidity, providing that at least $4 million must be maintained at all times on or after April 30, 2019 rather than beginning on March 31, 2019;
|
|
(ii)
|
the maximum total leverage ratio (ratio of total debt borrowed by the Company and its subsidiaries to EBITDA), providing that the maximum total leverage ratio shall not exceed 4.50:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which total leverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement; and
|
|
(iii)
|
the maximum debt service coverage
ratio (ratio of EBITDA (for the four consecutive fiscal quarters most recently ended, subject to certain adjustments set forth
in the Credit Agreement) to interest expense and payments for operating leases), providing that the maximum debt service coverage
ratio shall not exceed 1.25:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter
ending September 30, 2019, which debt service coverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement.
|
Warrant Amendments
On April 16, 2019, the Company
entered into an Amendment No. 1 to Common Stock Purchase Warrants with Marathon Asset Management LP, on behalf of certain entities
it manages, as warrant holders (collectively, the “Holders”) (collectively, the “Marathon Warrant Amendments”),
amending certain terms of the existing warrants issued by the Company in favor of each Holder. Pursuant to the Marathon Warrant
Amendments, unless the Company has obtained the approval of its shareholders as required by the Nasdaq Capital Market, the number
of shares to be issued under warrants held by the Holders shall not exceed 19.99% of the issued and outstanding common stock of
the Company as of December 31, 2018. The Marathon Warrant Amendments also provide that the failure to obtain shareholder approval
of an increase in the number of authorized shares of common stock of the Company, sufficient to enable the Company to issue common
stock upon exercise of the warrants held by each Holder, will constitute an event of default under the existing credit agreement
among the Company, as borrower, the Holders, as lenders, and Wilmington Trust, National Association, as the agent.
On April 17, 2019, the Company and Arosa Opportunistic Fund LP (“Arosa”) entered into Amendment
No. 1 to Common Stock Purchase Warrant (the “Arosa Warrant Amendment”), amending certain terms of the existing warrants
issued by the Company. Pursuant to the Arosa Warrant Amendment, until the Company obtains shareholder approval of an increase in
the number of authorized shares of common stock of the Company, the Company will not be required to reserve shares of common stock
for issuance under the warrants held by Arosa. If the Company does not increase the number of authorized shares of common stock
by June 30, 2019, the amendment will be null and void.
Subscription
Agreement
On
April 30, 2019, the Company entered into a subscription agreement (the “Subscription Agreement”), with certain investors
(the “Investors”) pursuant to which the Company agreed to issue and sell, in a registered public offering by the Company
directly to the Investors (the “Registered Direct Offering”), 3,957,432 shares of Common Stock. The purchase price
per share was $0.74.
The
closing of the Registered Direct Offering occurred on May 1, 2019. The Subscription Agreement contains customary representations,
warranties and agreements by us and customary conditions to closing. The representations, warranties and covenants contained in
the Subscription Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit
of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties.
The
net proceeds to the Company are expected to be approximately $2.9 million, after deducting estimated expenses payable
by the Company associated with the Registered Direct Offering. The Company expects to use the net proceeds from this offering for
working capital, general corporate purposes and repayment of debt and other obligations.
Third
Amendment to Credit Agreement
On
April 30, 2019, the Company entered into the Third Amendment to Credit Agreement (the “Marathon Third Amendment”),
among the Company, as borrower, certain affiliates of Marathon Asset Management, LP, as lenders (collectively, with their permitted
successors and assignees, the “Lenders”), and Wilmington Trust, National Association, as the agent (“Wilmington”)
amending certain terms of the Credit Agreement, dated as of December 31, 2018 (as amended, restated, amended and restated or otherwise
modified prior to the date hereof), between the Company, the Lenders and Wilmington. The Marathon Third Amendment amended the minimum
liquidity covenant, providing that at least $4 million must be maintained at all times at or after May 31, 2019 rather than at
all times on or after April 30, 2019. Unless the Company fails to maintain minimum liquidity as of the last day of any calendar
month, the Company may cure a failure to maintain minimum liquidity by increasing liquidity to $4,000,000 within five business
days of the occurrence.